Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (13078)	8/11/1998 7:39:00 PM
From: Stephen O'Hara	Read Replies (2) \| Respond to of 23519

There is only so many times you can flirt with your 52 week low and not pierce it. I was afraid of this when we only slightly budged off the 52 week low and closed at 6.03 on Friday. Incidentally, I saw 29K dumped a couple minutes after the bell. I was very encouraged as we bounced off 5.25 and went over 5.5, but we lost steam again to the close. I really wouldn't be too concerned about today given the overall picture of the market, but slipping under 2 key levels of support is a flaming red flag to powerful people with a ton of shares, and the marginability level at 5 scares the $#!+ out of individual investors with shares on margin. If we dip under $5, there's alway a possibility of that uncomfortable zone that ranges from Overexaggeration to Panic with small investors raising the white flag of surrender as they "surrender" their shares on Margin. Really thought we would have rallied or at least bounced in the last couple of days. Nothin' Reminds me of the movie "Fletch" with Chevy Chase when Mr. Underhill works-over the waitor. "I bet your expecting a nice gratuity, right?" He walks away without leaving a cent and says, "Maybe Next Time." I bet your expecting to bounce-off these welfare-like levels, right... Hey Doc, I really love your stewardship over this company. By the way, meet Mr. Underhill." Better Days, Gang Steve O'Hara

To: Mkilloran who wrote (13078)	8/11/1998 7:45:00 PM
From: VLAD	Respond to of 23519

From the stock price you would think that we are not an important player in the ED field. Hold on longs and let things play themselves out for the longer term. I know things look ugly but until Vivus proves to the Street that they are going to be a profitable ED player, we will continue to suffer. Here is some info about Vivus in England (the only other foreign country that is fully launched). Yahoo! Pager - Keep track of friends online, get instant messages Message Boards Help - Edit Public Profile - Personalize - SignÿOut Top:Business and Finance:Stocks:Healthcare:Biotechnology and Drugs:VVUS (Vivus, Inc.) <- Previous Next -> Message 15110 of 15129 Reply muse has 53% of UK market riskman2000 Aug 11 1998 12:18PM EDT I called Astra in UK at # provided at Vivus website.I spoke with a Jonathan Walker who who told me he can not talk about Vivus sales and refered me to Vivus UK headquarters(I did not know they had one).I asked him if he could give me any info at all,and he said "the only thing I can say is that Muse has captured 53% of the prescription market for ED treatments".I tried calling the Vivus HQ and it has been busy every time I dial.The number to dial from the states is 011 44 017538422007 if anyone wants to try,keep in mind they are 6 hours ahead of CST.Mr. Walker told me Vivus will be able to give me info on sales etc. ÿ VVUS:ÿ Quote ÿ\|ÿ Profile ÿ\|ÿResearch This Is a Reply to: Msg 15107 by bull_in_bears_cloathing <- Previous Next -> Message 15110 of 15129 Reply ÿÿ -------------------------------------------------------------------------------- Go to: Startÿ\|ÿMost Recentÿ\|ÿMessage List \| Message Number:ÿ ÿ ÿ -------------------------------------------------------------------------------- Terms and Conditions Yahoo! is a trademark of Yahoo! Inc. Copyright c 1994-98 Yahoo! All Rights Reserved. Don't think that Viagra will have a free for all in Europe as it did in the States. It will be strictly regulated and it will not be covered by many of the government health plans.